Evidence map›Paper›PMID 33856106›Full record

ArticleAngewandte Chemie (International ed. in English)2021

Development of Continuous Flow Systems to Access Secondary Amines Through Previously Incompatible Biocatalytic Cascades*.

Ashley P Mattey, Grayson J Ford, Joan Citoler, Christopher Baldwin, James R Marshall, Ryan B Palmer, Matthew Thompson, Nicholas J Turner, Sebastian C Cosgrove, Sabine L Flitsch

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Monitoring and control of the release of soluble OBiotechnology and bioengineering · 2022
    Article
  13. Review
  14. Article
  15. Review
  16. New Trends and Future Opportunities in the Enzymatic Formation of C-C, C-N, and C-O bonds.Chembiochem : a European journal of chemical biology · 2022
    Review
  17. Reaching New Biocatalytic Reactivity Using Continuous Flow Reactors.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Review
  18. Oxidase enzymes as sustainable oxidation catalysts.Royal Society open science · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ashley P MatteyManchester Institute of Biotechnology (MIB) &, School of Chemistry, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.ORCID 0000-0002-6564-7150
Grayson J FordManchester Institute of Biotechnology (MIB) &, School of Chemistry, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.
Joan CitolerManchester Institute of Biotechnology (MIB) &, School of Chemistry, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.
Christopher BaldwinManchester Institute of Biotechnology (MIB) &, School of Chemistry, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.
James R MarshallManchester Institute of Biotechnology (MIB) &, School of Chemistry, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.
Ryan B PalmerManchester Institute of Biotechnology (MIB) &, School of Chemistry, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.
Matthew ThompsonEnginzyme AB, Tomtebodevägen 6, 17165, Stockholm, Sweden.
Nicholas J TurnerManchester Institute of Biotechnology (MIB) &, School of Chemistry, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.ORCID 0000-0002-8708-0781
Sebastian C CosgroveManchester Institute of Biotechnology (MIB) &, School of Chemistry, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.ORCID 0000-0001-9541-7201
Sabine L FlitschManchester Institute of Biotechnology (MIB) &, School of Chemistry, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.ORCID 0000-0003-3974-646X

Funding

Biotechnology and Biological Sciences Research Council BB/ L013762/1Biotechnology and Biological Sciences Research Council BB/M027791/1Biotechnology and Biological Sciences Research Council BB/ M028836/1Biotechnology and Biological Sciences Research Council BB/M02903411
6 · The paper itself

Abstract

A key aim of biocatalysis is to mimic the ability of eukaryotic cells to carry out multistep cascades in a controlled and selective way. As biocatalytic cascades get more complex, reactions become unattainable under typical batch conditions. Here a number of continuous flow systems were used to overcome batch incompatibility, thus allowing for successful biocatalytic cascades. As proof-of-principle, reactive carbonyl intermediates were generated in situ using alcohol oxidases, then passed directly to a series of packed-bed modules containing different aminating biocatalysts which accordingly produced a range of structurally distinct amines. The method was expanded to employ a batch incompatible sequential amination cascade via an oxidase/transaminase/imine reductase sequence, introducing different amine reagents at each step without cross-reactivity. The combined approaches allowed for the biocatalytic synthesis of the natural product 4O-methylnorbelladine.

Indexed as

Alcohol OxidoreductasesAminesBiocatalysisBiological ProductsMolecular Structurealcohol oxidaseAlcohol OxidoreductasesAminesBiological Productsbiocatalytic cascadescontinuous flowoxidationreductive aminationtransamination

Identifiers

PMID33856106
PMCPMC8453870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.